Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06566807
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
Oxygen Study-Orelabrutinib Combined With ObinutuzumabO2 for First-Line Treatment of Marginal Zone Lymphoma
Sponsor:
Organization:
None